Al-Shamma; Hussien A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Al-Shamma; Hussien A..The latest application filed is for "combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level".

Company Profile

0.13.24

Al-Shamma; Hussien A. - Encinitas CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Grant 8,198,232 - Chu , et al. June 12, 2	2012-06-12
Methods for identifying GLP-1 secretagogues Grant 8,030,270 - Chu , et al. October 4, 2	2011-10-04
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Grant 8,022,034 - Chu , et al. September 20, 2	2011-09-20
Combination Therapy For The Treatment Of Diabetes And Conditions Related Thereto And For The Treatment Of Conditions Ameliorated By Increasing A Blood Glp-1 Level App 20100298333 - Chu; Zhi-Liang ; et al.	2010-11-25
Combination Therapy For The Treatment Of Diabetes And Conditions Related Thereto And For The Treatment Of Conditions Ameliorated By Increasing A Blood Glp-1 Level App 20100291589 - Chu; Zhi-Liang ; et al.	2010-11-18
Combination Therapy For The Treatment Of Diabetes And Conditions Related Thereto And For The Treatment Of Conditions Ameliorated By Increasing A Blood Glp-1 Level App 20100286111 - Chu; Zhi-Liang ; et al.	2010-11-11
Combination Therapy For The Treatment Of Diabetes And Conditions Related Thereto And For The Treatment Of Conditions Ameliorated By Increasing A Blood Glp-1 Level App 20100286168 - Chu; Zhi-Liang ; et al.	2010-11-11
Combination Therapy For The Treatment Of Diabetes And Conditions Related Thereto And For The Treatment Of Conditions Ameliorated By Increasing A Blood Glp-1 Level App 20100285495 - Chu; Zhi-Liang ; et al.	2010-11-11
Combination Therapy For The Treatment Of Diabetes And Conditions Related Thereto And For The Treatment Of Conditions Ameliorated By Increasing A Blood Glp-1 Level App 20100285494 - Chu; Zhi-Liang ; et al.	2010-11-11
Combination Therapy For The Treatment Of Diabetes And Conditions Related Thereto And For The Treatment Of Conditions Ameliorated By Increasing A Blood Glp-1 Level App 20100286153 - Chu; Zhi-Liang ; et al.	2010-11-11
Combination Therapy For The Treatment Of Diabetes And Conditions Related Thereto And For The Treatment Of Conditions Ameliorated By Increasing A Blood Glp-1 Level App 20100286172 - Chu; Zhi-Liang ; et al.	2010-11-11
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Grant 7,803,753 - Chu , et al. September 28, 2	2010-09-28
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Grant 7,803,754 - Chu , et al. September 28, 2	2010-09-28
Substituted heterocycles for the treatment of diabetes and other diseases Grant 7,226,940 - Pfahl , et al. June 5, 2	2007-06-05
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level App 20070072804 - Chu; Zhi-Liang ; et al.	2007-03-29
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level App 20070072803 - Chu; Zhi-Liang ; et al.	2007-03-29
Bicyclic heterocycles for the treatment of diabetes and other diseases Grant 7,196,108 - Pfahl , et al. March 27, 2	2007-03-27
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases Grant 7,153,875 - Pfahl , et al. December 26, 2	2006-12-26
Heterocyclic amide derivatives for the treatment of diabetes and other diseases App 20060241138 - Pfahl; Magnus ; et al.	2006-10-26
Heterocyclic amide derivatives for the treatment of diabetes and other diseases Grant 7,102,000 - Pfahl , et al. September 5, 2	2006-09-05
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases App 20060160796 - Pfahl; Magnus ; et al.	2006-07-20
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level App 20060154866 - Chu; Zhi-Liang ; et al.	2006-07-13
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases Grant 7,071,218 - Pfahl , et al. July 4, 2	2006-07-04
Imidazolidinedione derivatives for the treatment of diabetes and other diseases Grant 6,974,826 - Pfahl , et al. December 13, 2	2005-12-13
RXR activating molecules App 20050209286 - Pfahl, Magnus ; et al.	2005-09-22
Imidazolidinedione derivatives for the treatment of diabetes and other diseases App 20050070581 - Pfahl, Magnus ; et al.	2005-03-31
Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases App 20050038098 - Tachdjian, Catherine ; et al.	2005-02-17
Thiazolidinedione derivatives for the treatment of diabetes and other diseases Grant 6,765,013 - Pfahl , et al. July 20, 2	2004-07-20
2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer App 20040097566 - Pfahl, Magnus ; et al.	2004-05-20
Bicyclic heterocycles for the treatment of diabetes and other diseases App 20040034004 - Pfahl, Magnus ; et al.	2004-02-19
Heterocyclic amide derivatives for the treatment of diabetes and other diseases App 20030216432 - Pfahl, Magnus ; et al.	2003-11-20
Thiazolidinedione derivatives for the treatment of diabetes and other diseases App 20030153606 - Pfahl, Magnus ; et al.	2003-08-14
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases App 20030144329 - Pfahl, Magnus ; et al.	2003-07-31
RXR activating molecules App 20030105333 - Pfahl, Magnus ; et al.	2003-06-05
Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia App 20030083357 - Pfahl, Magnus ; et al.	2003-05-01
Heterocyclic derivatives for the treatment of diabetes and other diseases Grant 6,515,003 - Pfahl , et al. February 4, 2	2003-02-04
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases App 20020143182 - Pfahl, Magnus ; et al.	2002-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.